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Phylogenetic and phenotypic analysesFour serotypes of dengue virus (DENV 1–4) currently circulate between humans and domestic/peridomestic
Aedes mosquitoes, resulting in 100 million infections per year. All four serotypes emerged, independently,
from sylvatic progenitors transmitted among non-human primates by arboreal Aedes mosquitoes. This
study investigated the genetic and phenotypic changes associated with emergence of human DENV-4 from
its sylvatic ancestors. Analysis of complete genomes of 3 sylvatic and 4 human strains revealed high conser-
vation of both the 5′- and 3′-untranslated regions but considerable divergence within the open reading
frame. Additionally, the two ecotypes did not differ signiﬁcantly in replication dynamics in cultured human
liver (Huh-7), monkey kidney (Vero) or mosquito (C6/36) cells, although signiﬁcant inter-strain variation
within ecotypes was detected. These ﬁndings are in partial agreement with previous studies of DENV-2,
where human strains produced a larger number of progeny than sylvatic strains in human liver cells but
not in monkey or mosquito cells.
© 2011 Elsevier Inc. All rights reserved.Introduction
There is growing concern about the potential emergence of new
pathogens, particularly arthropod-borne viruses (arboviruses), from an-
imal reservoirs into humans (Weaver and Reisen, 2010; Wilder-Smith
and Gubler, 2008). To gain insight into this process of emergence, it is
particularly instructive to study viruses that have completed the trajec-
tory from an enzootic into a human reservoir, such as the four serotypes
of dengue virus (DENV-1–4, genus Flavivirus, family Flaviviridae). These
viruses originated in a sylvatic cycle between nonhuman primates, and
possibly other enzootic hosts, and arboreal Aedes (Ae.) mosquitoes.
Each serotype emerged independently into a human transmission
cycle, wherein humans now serve as the exclusive reservoir and ampli-
ﬁcation hosts for the endemic/epidemic lineages (Vasilakis et al., 2011).
In this human cycle, DENV-1,-2,-3, and -4 are transmitted by domestic
and peridomestic Aedes mosquitoes, primarily Ae. aegypti aegypti and
Ae. albopictus (Halstead, 1997; Halstead et al., 1964; Rosen et al., 1954;
Sabin, 1952; Simmons et al., 1931). The human DENV cycle is presently
found in nearly all urban and peri-urban environments throughout the
tropics and subtropics. In recent decades, DENV transmission amongEmerging Infectious Diseases
tion and Immunity, and Center
ch, Galveston, TX 77555-0610,
rights reserved.humans has intensiﬁed due to increased travel, uncontrolled urbaniza-
tion and lack of effective and sustainable vector control programs
(Guzmanet al., 2010). By current estimates, DENV infects approximately
100 million people each year in over 100 countries.
Unlike the ancestors ofmany other human viruses, the ancestral syl-
vatic cycle of DENV remains extant and has been documented in two
foci: one in West Africa involving arboreal Aedes spp. (e.g. Ae. furcifer,
Ae. luteocephalus) and primates including patas monkeys (Erythrocebus
patas), African green monkeys (Chlorocebus sabaeus), and Guinea ba-
boons (Papio papio) (Cordellier et al., 1983, Diallo et al., 2003, 2005;
Hervy et al., 1984; Rodhain, 1991; Saluzzo et al., 1986a; Vasilakis et
al., 2008c) and the other in peninsular Malaysia involving Ae. niveus s.
l. and primates including cynomolgus macaques (Macaca fascicularis),
pig-tailed macaques (Macaca nemestrina) and silvered leaf monkeys
(Presbytis cristata) (Rudnick, 1986). The continued circulation of sylvat-
ic DENVprovides an opportunity to perform comparative studies to elu-
cidate the virus attributes that promote arboviral emergence. However
these sylvatic viruses also pose a considerable threat, because they may
retain the capacity to re-emerge even as efforts to control circulation of
human dengue intensify (Vasilakis et al., 2011), in a manner analogous
to urban yellow fever.
Although sylvatic and human DENV strains show substantial genetic
differences, our previous studies of DENV-2 demonstrated that such dif-
ferences do not constitute an adaptive barrier to emergence into the
human transmission cycle. Speciﬁcally sylvatic DENV-2 showed no de-
tectable deﬁcit relative to human DENV-2 in replication kinetics in
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cation in two proxy measures for human infection, monocyte-derived
dendritic cells and SCID mice engrafted with human hepatoma cells
(Vasilakis et al., 2007b), or in infection of Ae. aegypti and Ae. albopictus
in vivo (Hanley and Vasilakis, unpublished data). Furthermore, some
sylvatic Aedes species sympatric with sylvatic DENV are capable of
transmitting these viruses and may act as bridge vectors when they
move between forest and human habitations. For example inWest Afri-
ca a highly susceptible vector of sylvatic DENV, the forest-dwelling Ae.
furcifer, (Diallo et al., 2005), disperses into villages (Diallo et al., 2003),
while in Southeast Asia, Ae. albopictus disperses from the forest into sur-
rounding agricultural settlements (Smith, 1956). Both species bite
humans, resulting in potential transmission of sylvatic DENV to humans.
Indeed, several reports have now documented spillover of sylvatic
DENV, resulting in infection of individual humans or small outbreaks
(Cardosa et al., 2009; Carey et al., 1971; Franco et al., 2011; Monlun et
al., 1992, Saluzzo et al., 1986a, 1986b; Vasilakis et al., 2008c). Currently
it is not possible to distinguish sylvatic and human DENV infections
with antibody-based assays, and thus sylvatic DENV infections may fre-
quently be misclassiﬁed as human DENV. Nonetheless two recent re-
ports from Southeast Asia (Cardosa et al., 2009) and West Africa
(Franco et al., 2011) reveal that sylvatic DENV infections can result in se-
vere disease.
Collectively, these data indicate that DENV has evolved as an eco-
logical generalist capable of utilizing a broad range of Aedes vectors
and primate hosts (including humans) and suggest that the public
health impact of sylvatic dengue spillover may be substantially great-
er than is currently appreciated. However to date the vast majority of
both experimental (Cox et al., 2011; Mota and Rico-Hesse, 2009,
2011; Vasilakis et al., 2007b, 2008a, 2008b, 2009) and phylogenetic
(Vasilakis et al., 2007a) studies of sylvatic DENV have focused exclu-
sively on DENV-2, and it is critical to extend these efforts to encom-
pass the full range of genetic and phenotypic diversities within
sylvatic DENV. Thus, we investigated the genetic relationships of syl-
vatic and human DENV-4 using complete genome sequences from
each ecotype. Previous studies have generated phylogenies of
DENV-4 that include a only a single sylvatic DENV-4 isolate or a single
gene from the all 3 known sylvatic DENV-4 isolates (AbuBakar et al.,
2002; Wang et al., 2000); in this study we utilized the complete ge-
nome sequences of the three sylvatic DENV-4 isolates as well as 59
human DENV-4 sequences from GenBank that represent the complete
genotypic diversity known for this serotype. To better link genetic
and phenotypic variations, we also measured the replication kinetics
of a subset of human versus sylvatic isolates in both mammalian and
mosquito cells in culture.
Results and discussion
Phylogenetic analyses
Complete genome sequences from 59 human DENV-4 isolates that
span the genetic, geographic and temporal ranges of DENV-4 diversi-
ty (Chen and Vasilakis, 2011; Holmes and Twiddy, 2003; Vasilakis
and Weaver, 2008; Villabona-Arenas and Zanotto, 2011; Weaver
and Vasilakis, 2009) as well as the only 3 known sylvatic DENV-4
strains (Rudnick, 1986) were used for phylogenetic analysis. Fig. 1
shows a representative phylogenetic tree derived from Bayesian anal-
ysis; several consensus trees obtained based on Maximum-likelihood
(ML) and Bayesian analyses exhibited similar topologies.
All 3 sylvatic DENV-4 strains were genetically distinct from and
basal to human DENV-4 strains. Among the sylvatic strains, P73-
1120 and P75-514 were more closely related to each other than to
the P75-215 strain, an observation that reﬂects their history. Strain
P73-1120 was isolated from a sentinel silver leaf monkey (P. cristata)
in the Gunong Besut forest reserve in Malaysia in 1973 (Table 1). Two
years later an aliquot of the original serum sample collected from thesentinel monkey was used for experimental infections of silver leaf
monkeys, which led to the isolation of P75-514 strain (Rudnick,
1986). Our sequences indicated that, during this single passage, sev-
eral mutations occurred, which were primarily synonymous and
resulted in a 0.1% nucleotide divergence from the parent strain P73-
1120 (Table 1). Strain P75-215 was isolated in 1975 from a pool of
Ae. niveus s. l.mosquitoes collected in the forest canopy of the Gunong
Besut forest reserve in late 1974 (Rudnick, 1986).
As shown in previous studies (AbuBakar et al., 2002; Bennett et al.,
2003; Foster et al., 2003; Klungthong et al., 2004; Vasilakis and
Weaver, 2008; Villabona-Arenas and Zanotto, 2011; Weaver and
Vasilakis, 2009), human DENV-4 strains clustered into three major
genotypes. Genotype I includes strains from the Philippines, Thailand,
Vietnam, Myanmar, Malaysia, Sri Lanka, and India (Cecilia et al., 2011;
Dash et al., 2011). The India G11337 strain, which was isolated in
1961 and is therefore one of the oldest DENV-4 strains sampled, is ge-
netically distinct and basal to other isolates of this clade. Genotype II
is composed of two distinct sub-lineages: IIa, including strains from
Malaysia, Thailand and Taiwan and IIb, comprising strains from the
Caribbean and the Americas (Bennett et al., 2003; Foster et al.,
2003). Genotype III includes Thai strains sampled between 1997
and 2001 that are distinct from the Thai isolates of genotype II
(Klungthong et al., 2004).
Genetic analysis
The DENV genome is comprised of approximately 10.7 kilobases
(kb) of single stranded RNA of positive polarity. A single open reading
frame (ORF) of 10,164 nucleotides (Table 2) is ﬂanked by untranslated
regions (UTRs) at the 5′ and 3′ ends. The 5′-UTR is 101 nt long and is
capped with a type I 5′cap (Cleaves and Dubin, 1979; Lindenbach and
Rice, 2003), while the 402 nt 3′-UTR lacks the classical polyadenylation
site (Wengler et al., 1978) (Table 2).
5′- and 3′- UTRs
The sequences of both the 5′ and 3′ UTRs are highly conserved
among the four DENV serotypes (Markoff, 2003). In the DENV-4 strains
analyzed, the sequence of both UTRs was highly conserved, and the 5′
UTR had a higher sequence identity between the strains (ranging
from 95.2 to 98.0%) than the 3′ UTR (88.7–95.1%) (Table 2; sequence
data is presented in Supplemental Data Figs. 1 and 2). The 5′ cyclization
sequence (5′CS) locatedwithin the coding region of the capsid gene (nt
35–42 after the start codon) (Hahn et al., 1987) was present in all
strains analyzed. The ﬂavivirus 3′ UTR comprises three sub-regions:
the Variable Region (VR), core, and 3′ terminus (Markoff, 2003). Several
previously identiﬁed conserved regionswithin the core and 3′ terminus
(RCS2, CS2 and CS1 and CPS (Hahn et al., 1987)) were present in both
the sylvatic and human strains (Supplemental Data 3C, D). The highly
conserved 3′ terminal dinucleotide of the plus-strand (UC-3′) was pre-
sent in all DENV-4 sequences for which the 3′ terminal sequence was
available, and was complementary to the 5′-terminal dinucleotides (5′
AG), purportedly enabling cyclization of the genome during the early
stages of replication (Markoff, 2003; Rice et al., 1985; Wengler and
Wengler, 1981). Relative to the sylvatic strains, the VR of human geno-
types I–III exhibited 3, 13 or 15 nt deletions, respectively (Supplemental
Data 2). A similar accrual of deletions in human strains relative to syl-
vatic strains has been documented in DENV-2 strains (Vasilakis et al.,
2008b), and other investigators (Leitmeyer et al., 1999; Shurtleff et al.,
2001) have suggested that these deletions occurred during the evolu-
tion of human strains from sylvatic progenitors. Proutski et al. (1999)
suggested that the VR region may act as a spacer to protect conserved
and structurally important distal regions but the precise effects of
these particular deletions in human strains have not been determined.
The predicted RNA secondary structures of representative sylvatic
(P73-1120) and human (IndiaG11337) DENV-4 strains were ex-
tremely similar at the 5′ and 3′ UTRs (Supplemental Data Figs. 3A–
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Fig. 1. Phylogenetic analysis of sylvatic DENV-4 isolates. Phylogenetic tree derived from complete genome nucleotide sequences of sylvatic and human DENV-4 strains using Bayes-
ian analysis. Numbers of posterior probability values for monophyletic groups to the right. Asterisks indicate DENV strains used to evaluate replication kinetics. Virus strains are
coded by abbreviated country of collection/strain name/year of collection. The scale shows a genetic distance of 0.02 or 2% nucleotide sequence divergence.
60 S.L. Rossi et al. / Virology 423 (2012) 58–67D) and were also similar to previously predicted structures for these
regions (Markoff, 2003; Rauscher et al., 1997; Romero et al., 2006;
Thurner et al., 2004; Yu et al., 2008). As in previous predictions of
the 5′ UTR in isolation (Brinton and Dispoto, 1988), the RNA second-
ary structure of each strain contains a long stem loop (SLA) with a
shorter side loop (SLB) closest to the start codon; alterations to this
sequence may affect RNA-dependent RNA polymerase bindingTable 1
Characterization of genetic sequence of selected dengue-4 sylvatic strains.
Virusa Ecotypeb Location Hostc
H241 Human The Philippines Human
IndiaG11337 Human India Human
INH6412 Human Venezuela Human
Haiti73 Human Haiti Human
P73-1120 Sylvatic Malaysia A. niveus s.l.
P75-514 Sylvatic Malaysia Presbytis cristata (experimental infection)
P75-215 Sylvatic Malaysia Presbytis cristata (Sentinel monkey)
a Low passage DENV isolates were obtained from the UTMBWorld Reference Center for Em
sufﬁciently high titers for further evaluation.
b Human indicates isolates associated with the human transmission cycle or associated w
mosquito isolate; see also Fig. 1 for phylogenetic groupings.
c Source of virus isolation.
d Denotes % identity compared to endemic H241 reference strain.
e Partial sequence; the 3′ terminus of the 3′UTR is missing.(Filomatori et al., 2011) and viral replication (Cahour et al., 1995;
Filomatori et al., 2006). There has been disagreement in the predic-
tion of the DENV-4 CS2, with some studies showing a dumbbell struc-
ture and others showing a single turret (Gritsun and Gould, 2006;
Proutski et al., 1999; Romero et al., 2006). The current study found
a dumbbell structure at this region for both the sylvatic and human
strain. CS2 is particularly important because it is the site of theYear GenBank
accession no.
Genome
length
% nt
identityd
% aa
identityd
ORF
(nt)
5′UTR
(nt)
3′UTR
(nt)
1956 AY947539 10,643e – – 10,164 101 282e
1961 JF262783 10,659 95.1% 99.2% 10,164 101 394
1995 JF262781 10,649 94.3% 99.1% 10,164 101 384
1994 JF262782 10,649 94.3% 99.1% 10,164 101 384
1975 EF457906 10,667 86.9% 98.3% 10,164 101 402
1975 JF262779 10,667 87.0% 98.3% 10,164 101 402
1973 JF262780 10,666 86.9% 98.3% 10,164 101 401
erging Viruses and Arboviruses and ampliﬁed once on C6/36 mosquito cells to achieve
ith peridomestic transmission; sylvatic indicates sentinel monkey or canopy-dwelling
Table 2
Nucleotide identity (%) between the consensus sequence of the 5′-UTR (above the di-
agonal) and 3′-UTR (below the diagonal) of human DENV-4 genotypes I–III and sylvatic
DENV-4.
5′-UTR Genotype I Genotype II Genotype III Sylvatic
Genotype I 100.0 96.2 97.1 98.0
Genotype II 93.1 100.0 95.2 96.2
Genotype III 93.8 95.1 100.0 97.0
Sylvatic 91.9 88.7 88.9 100.0
Table 3
Summary of consistent amino acid differences between sylvatic and human DENV-4
genotypes.
Gene Sitea Typeb AA
substitution
Comment
C 8 I–III A→V
34 III T→ I
34 II T→S T→T: PR 1995 strains
74 III N→T
81 I–II T→ I
102 III M→V
102 I–II M→ I
111 I–III I→V
prM 5 I–III S→T
41 I–III V→L
70 I–III S→L
76 I–III T→M
83 III S→N
M
(mature)
6 I–III A→T
17 I–III T→A
E 4 III V→ I
19 I–III T→A
46 I–II I→T I→ I: G11337;0348;0087; 0485; BID-
V3361
132 I–III V→ I
148 I–III A→T
154 I–III S→D
162 I–III T→A
174 III K→E
182 III T→S
202 III K→E
203 I–III G→K
233 III Y→H
265 I – II T→A
310 III K→R
329 I–II T→A
335 I–III I→V
340 I–III K→R
342 I–III M→V
351 I I→V
355 I–III I→T
357 II F→L
364 I – III I→V
382 I–III A→V
384 II D→N
455 III I→V
461 I–II I→F
461 III I→L
474 III S→P
478 I–III S→T S→S: G11337;0348;0087; 0485; BID-
V3361
NS1 9 III S→T
22 I–II I→V
22 III I→T
33 III K→Q
57 I–III V→ I
90 I–III T→A
98 III T→V
103 I–III V→A
104 I–III I→L
105 I–III A→T
129 III R→K
131 I–III N→S
152 II F→S
153 I L→F L→L: G11337;0348;0087; 0485; BID-
V3361
156 I–III D→E
166 III N→S
171 I–III L→F
188 I–III V→ I
192 I–III R→K
246 I–II T→S
251 I–III S→F
265 II M→Y
275 I–III M→ I
292 I–III G→D
338 I–III S→L
(continued on next page)
61S.L. Rossi et al. / Virology 423 (2012) 58–67delta30 mutation that has been used for generation of dengue virus
vaccines (Durbin andWhitehead, 2010). Moreover this 30 nt deletion
confers attenuation on some but not all DENV strains (Blaney et al.,
2004a, 2004b; Durbin et al. 2011). Thus experimental analysis of the
structure of this region in sylvatic DENV-4 would be particularly valu-
able once a reverse genetics system is established.
Open reading frame (ORF)
To identify sequence differences between sylvatic DENV-4 and each
of the genotypes of humanDENV-4, we generated bothmultiple ORF se-
quence alignments that included DENV-4 strains from all genotypes as
well as human and sylvatic transmission cycles (Fig. 1 and Materials
andmethods section). Consistent differences between the ancestral syl-
vatic and derived human strains were inferred to be mutations in the
human strains. These comparisons revealed a large number of nucleo-
tide differences, most of which were nonsynonymous (Table 3).
Structural proteins
The DENV capsid (C) is a small, positively charged protein (Trent,
1977) containing membrane-associated alpha-helical structures (Jones
et al., 2003; Markoff et al., 1997) that form the inner core of the virion.
There are 6 positions that show differences between the sylvatic and
human strains with most nonsynonymous mutations located outside
of predicted alpha-helical regions (Table 3).
The prM protein is the immature precursor to the membrane (M)
protein found in the virions, and forms a scaffold over the viral envelope
(E) protein to prevent premature fusion during virion maturation (Li et
al., 2008). Seven non-synonymous differences between the sylvatic and
human DENV4 strains were detected, 2 of which are found within the
mature M protein (Table 3).
The E protein comprises the majority of the surface area on the ma-
ture virion and is responsible for receptor binding (Chen et al., 1996;
Johnson et al., 1994; Rey et al., 1995) and host cell surface fusion
(Modis et al., 2004). Of the 29 amino acid changes (Table 3), no changes
occurred to the 12 conserved disulﬁde bridge-forming cysteine resi-
dues, to the twoN-linked glycosylation sites in the E protein at residues
N67 and N153 (Johnson et al., 1994; Zhao et al., 1986), or to proposed
heparan sulfate binding sites (Chen et al., 1997; Modis et al., 2005).
Given strong antibody neutralization of both sylvatic and human strains
of the same serotype by antibodies raised against either ecotype
(Vasilakis et al., 2008a) it was not surprising that highly immunogenic
residues 104, 106, 107 (located in the fusion loop) and 126, 226 and
231 (Crill and Chang, 2004) remain unchanged between sylvatic and
human strains. Interestingly, mutations were observed within the DIII
region at positions 310 and 364, which are potentially signiﬁcant
since they are located within the binding domains of several well-
characterized monoclonal antibodies including 4E11 (Thullier et al.,
2001) and 9D12 (Crill et al., 2009).
Nonstructural proteins
The functions of NS1 are not completely known. Like the E protein,
NS1 contains 12 disulﬁde bridge-forming cysteine residues and en-
codes N-linked glycosylation sites at N130 and N207 (Pryor and
Wright, 1994). Of the 26 non-synonymous differences between the
sylvatic and human DENV-4 strains, none involved critical cysteines
Table 3 (continued)
Gene Sitea Typeb AA
substitution
Comment
341 III K→R
NS2A 4 III P→S
4 I–II P→T
19 III M→ I
26 III R→K
38 III A→T
38 II A→ I
40 III L→F
54 I–III V→L
57 I–II I→L
65 III F→L
65 I–II F→S
66 III G→S
68 III M→V
68 I–II M→ I M→M: G11337;0348;0087; 0485; BID-
V3361
72 III V→T
78 III A→ I
113 II F→L
127 I–III A→S
135 I–II M→ I M→M: G11337;0348;0087; 0485; BID-
V3361
137 I–III Y→T
138 II H→Q
142 I–III A→T
144 I–III L→V
155 I–III K→R
156 I–III T→S
161 III I→T
161 I–II I→V
169 I–III V→A
173 III V→A
197 I–II I→L
217 I–II K→R K→K: G11337;0348;0087; 0485; BID-
V3361
NS2B 55 III K→R
73 I–III V→ I
94 I–III L→M
116 III V→ I
119 II–III A→T
127 III K→R
NS3 12 I–II T→A
13 I–II A→T A→A: G11337;0348;0087; 0485; BID-
V3361
17 II M→A
17 I, III M→T
19 I–II T→S T→T: G11337;0348;0087; 0485; BID-
V3361
31 I–II L→F
40 I–III V→ I
42 I–III V→M
87 I–III E→D
100 I–III V→ I
142 II K→R
170 I–III K→R
190 I–III V→ I
249 I–III A→S
292 I S→C S→S: G11337;0348;0087; 0485; BID-
V3361
321 II T→A
322 II–III I→T
381 I K→R K→K: G11337;0348;0087; 0485;BID-
V3361
518 III R→K
538 I–III R→K
NS4A 20 I R→K R→R: G11337;0348;0087; 0485;BID-
V3361
58 I - III I→V
83 III M→V
87 II A→T
97 I–III I→V
140 I–II A→T
141 I–III L→ I
146 I–III S→G
148 III I→V
NS4B 11 III T→A
Table 3 (continued)
Gene Sitea Typeb AA
substitution
Comment
18 I–III E→V
20 I – III P→T
87 I–III S→G
93 I–III L→M
175 I A→V A→A: G11337;0348;0087; 0485;BID-
V3361
187 I F→L F→F: G11337;0348;0087; 0485;BID-
V3361
198 I–II A→ I
198 III A→V
199 I L→M L→L: G11337;0348;0087; 0485;BID-
V3361
205 I - III G→N
240 I–III T→A
NS5 42 I–III L→S
45 I K→R K→K: G11337;0348;0087; 0485;BID-
V3361
70 II I→V I→ I: G11337;0348;0087; 0485;BID-
V3361
90 I–III V→M
100 I–III R→K
102 I–III F→Y
163 I–III I→V
165 I–III R→K
199 I K→R K→K: G11337;0348;0087; BID-V3361
200 I–III Y→H
203 I, III N→S
205 I–II I→V
233 I–III V→T
234 I T→ I T→T: G11337;0348;0087; BID-V3361
235 I–III K→R
275 I–III V→ I
284 I Q→R Q→Q: 0348;0087;0485; BID-V3361
320 I–III I→V
367 III P→L
371 I–II V→M
372 I V→ I V→V: 0348;0087;0485; BID-V3361
386 I–II R→K
419 I–III A→T
432 I–III K→E
500 I–III D→E
520 II D→E
523 III K→R
525 I–III E→D
529 I M→ I
547 II L→Q
559 I–III G→H
561 III K→R
562 I I→T I→ I: G11337;0348;0087; 0485;BID-
V3361
585 II K→R
642 I–III K→R
648 II K→R
675 II S→G
717 I–III L→F
749 I–II K→R
785 I–III V→T
788 I–III V→F
831 I–III Y→H
854 I–III T→S
864 I–III Q→H
885 I–III A→V
887 III K→R
892 III P→L
893 II–III L→S L→F: G11337;0348;0087; 0485;BID-
V3361; 27949
Notes
Amino acid to the left represents amino acid in sylvatic viruses and to the right on the
human viruses. Arrows represent directionality of mutation.
a Indicated amino acid location from the start of the gene.
b I, II, III: represents genotypes I, II and III of dengue virus serotype 4.
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63S.L. Rossi et al. / Virology 423 (2012) 58–67or glycosylation sites. However, one mutation is found in all human
genotypes at position 131 (N131S) within the variable residue in
the NXT glycosylation signal at this site (Table 3). Furthermore recent
evidence suggests that epitope variation within NS1 (Chen et al.,
2010; Masrinoul et al., 2011) may inﬂuence progression to severe
dengue disease by a mechanism of molecular mimicry to human en-
dothelial cell antigens (Liu et al., 2011).Fig. 2. Comparative replication curves of DENV-4 strains. A–C: Daily virus output from days
human (Haiti73, IndiaG11337, INH6412 and H241) DENV-4 strains in mosquito cell line C6
Huh-7 (human hepatoma) (A–C, respectively). D–F: Mean virus output of human (squares)
tively); means derived from 3 strains of sylvatic and four human DENV-4 shown in panelsNS2A is a small, hydrophobic protein that in several ﬂaviviruses
plays a role in modulating the type I interferon (IFN) response
(Munoz-Jordan et al., 2003). Human DENV-4 strains differed from
sylvatic strains at 26 amino acids in NS2A (Table 3). The observed
high level of variability is characteristic of proteins involved in im-
mune suppression (Franzosa and Xia, 2011; Obbard et al., 2009).
NS2B is another small, hydrophobic protein that acts as a cofactor0–6 following infection at MOI 0.01 by sylvatic (P73-1120, P75-215 and P75-514) and
/36 (Ae. albopictus) and vertebrate cell lines Vero (African green monkey kidney) and
and sylvatic (diamonds) DENV-4 strains in C6/36, Vero, and Huh-7 cells (D–F, respec-
A–C. The limit of detection of the assay is 0.9 log10 ffu/mL.
64 S.L. Rossi et al. / Virology 423 (2012) 58–67for the enzymatic activity of NS3. Six nonsynonymous mutations
were detected (Table 3), none of which occurred at critical residues)
in NS2B required for NS3 function (Niyomrattanakit et al., 2004). NS3,
along with NS2B, has multiple functions including protease and heli-
case. Nineteen non-synonymous differences were noted (Table 3).
NS4A and NS4B are small, multifunctional, hydrophobic proteins
that have recently been shown to play a role in modulating the host's
type I IFN responses (Jones et al., 2005; Munoz-Jordan et al., 2003,
2005). Other functions of NS4A have not been fully elucidated, but it as-
sociates with host cell membranes (Jiang et al., 2009; Miller et al., 2007)
and is required for viral replication (Tajima et al., 2011). Nine differences
were observed (Table 3) in human NS4A DENV proteins. NS4B, which
has also been shown to act as a helper for the helicase function of NS3
(Umareddy et al., 2006) contained 11 differences between sylvatic and
human strains (Table 3). A previous study examining the evolutionary
pressures on sylvatic DENV-2 identiﬁed 13 sites in the NS4B gene
under weak positive selective pressure (Vasilakis et al., 2007a). This ob-
servation was striking in that no such sites were identiﬁed in human
DENV-2, and relatively few positively selected sites were identiﬁed in
any of the other genes in either of the two ecotypes. Four of the observed
NS4B mutations in this current study of DENV-4 (positions 11, 18, 20
and 198) were adjacent to sites under positive selection in sylvatic
DENV-2 (Vasilakis et al., 2007a).
NS5 acts as the RNA-dependent RNA-polymerase (RdRp) and is
responsible for RNA cap processing. Recently, anti-IFN activity of
NS5 has also been reported (Ashour et al., 2009). Forty-eight non-
synonymous differences were found in NS5 (Table 3), half of which
were seen in all genotypes. The N-terminus region has shown to be
responsible for methyltransferase activity, and residues critical for
this process (positions 14, 18, 29, 61, 146, 150 181 and 217) were
unchanged between sylvatic and human strains (Egloff et al., 2002).
Five non-synonymous mutations occur within the interdomain re-
gion between the N-terminal methyl transferase and the C-terminal
RdRp (positions 320–405) which contains two nuclear localization
signals (NLS) (Pryor et al., 2007), however all critical residues were
unaffected.
Phenotypic analyses
Replication kinetics of four human DENV-4 strains (Genotype I
IndiaG11337 and H241, as well as Genotype II Haiti73 and INH6412,
Table 1) and the 3 available sylvatic strains (P73-1120, P75-215 and
P75-514, Table 1) were characterized in primate kidney and human
hepatoma (Vero and Huh-7, respectively) and Ae. albopictus mosquito
(C6/36) cells. Cultured cells are admittedly an imperfect model of den-
gue replication in vivo; notably Vero cells and C6/36 cells are deﬁcient
in the IFN (Mosca and Pitha, 1986) and RNA interference response
(Brackney et al., 2010; Scott et al., 2010), respectively. However replica-
tion dynamics in these cells is sometimes correlated with replication in
vivo (Hanley et al., 2003) and therefore they offer a useful ﬁrst screen
for phenotypic variation among virus strains.
Titers of most viruses belonging to both human and sylvatic geno-
types increased in both C6/36 and Vero cells until day 4 post-infection
(p.i.) (Figs. 2A and B respectively), and in Huh-7 cells until day 5 p.i.
(Fig. 2C), after which titers stabilized or declined in all cell types. Huh-
7 cells exhibited pronounced cytopathic effect (CPE) by day 4 p.i.,
which became severe by 6 p.i. in response to infection with all DENV-4
strains (data not shown). Vero cells also exhibited CPE following infec-
tion by all strains, but it was less severe than that observed in Huh-7
cells; C6/36 cells exhibited no CPE.
Overall, ecotype (human or sylvatic) had no impact on patterns of
DENV-4 multistep replication kinetics in any of the 3 cells lines tested
(P>0.25 for all comparisons) (Figs. 2D–F). However signiﬁcant inter-
strain variation was detected within ecotypes during infection of the 3
cell types. The patterns of replication kinetics of individual strains in
each cell line are denoted in Figs. 2A–C. In C6/36 cells, both time(DF=7, F=4209.7, Pb0.0001) and virus (DF=6, F=132.3, Pb0.0001)
as well as the interaction between time and virus (DF=42, F=6.5,
Pb0.0001) had a signiﬁcant effect on viral replication dynamics. Notably,
the human India and H241 strains replicated to signiﬁcantly lower titers
than all other strains (Fig. 2A). In Vero cells, time (DF=7, F=5276.9.7,
Pb0.0001) and virus (DF=6, F=115.1, Pb0.0001) aswell as the interac-
tion between time and virus (DF=42, F=8.7, Pb0.0001) had signiﬁcant
effects on replication dynamics. Contrary to its performance in mosquito
cells, strain H241 replicated to signiﬁcantly higher levels than other
strains in Vero cells, while the India strain replicated to signiﬁcantly
lower levels than all other strains (Fig. 2B). In Huh-7 cells, both time
(DF=7, F=1009.8, Pb0.0001) and virus (DF=6, F=29.2, Pb0.0001)
as well as the interaction between time and virus (DF=42, F=4.6,
Pb0.0001), had a signiﬁcant effect on viral replication dynamics. Similar
to the pattern observed in Vero cells, H241 replicated to signiﬁcantly
higher levels than most other strains and IndiaG11337 replicated to sig-
niﬁcantly lower levels than all other strains (Fig. 2C).
In conclusion, our phylogenetic analyses of a diverse array of com-
plete DENV-4 genome sequences demonstrated that sylvatic DENV-4
isolates are basal to and evolutionarily distinct fromhumanDENV-4 iso-
lates, supporting previous classiﬁcations of DENV-4 into two discrete
ecotypes. This evolutionary and ecologic divergence is further corrobo-
rated by our genetic analyses, which revealed considerable differences
at both the nucleotide and protein levels between human and sylvatic
strains. While all sequence and structural elements previously identi-
ﬁed as critical for virus replication (i.e. UTR secondary structures, disul-
ﬁde bridges, and glycosylation sites) were fully conserved In both
ecotypes, nonetheless, we identiﬁed several amino acids that may
have played a role in the emergence of human DENV-4 strains from syl-
vatic progenitors. Human and sylvatic DENV-4 strains replicated with
similar dynamics in green monkey kidney cells, human hepatoma
cells and mosquito cells. These studies in cultured cells should be com-
plemented by testing the phenotypes of sylvatic versus human DENV-4
in peridomestic mosquitoes in vivo and in models for human replica-
tion. However the evidence to date suggests that sylvatic strains of
DENV-4 in Asia retain the potential to emerge into human transmission
cycles.Materials and methods
Viruses and sequencing
To avoid mutations resulting from adaptation to cell cultures, low
passage DENV-4 isolates of the following strains were obtained from
the World Reference Center for Emerging Viruses and Arboviruses
(WRCEVA) at the University of Texas Medical Branch: P75-514, P73-
1120 INH6412, JF262781, Haiti73, JF262782, India G11337, and
JF262783 (Table 1). All strains were ampliﬁed once in cultured C6/36
Ae. albopictus cells to achieve sufﬁciently high titers for ampliﬁcation
and sequencing.We have previously shown that DENV accumulates rel-
atively few mutations during passage in C6/36 cells (Vasilakis et al.,
2009). Initial overlapping cDNA fragments and amplicons of viruses
were generated using primer pairs speciﬁc to DENV P75-215 or H241
in a one-step (Roche Diagnostics, Indianapolis) or two-step (New En-
gland Biolabs, MA) reverse transcriptase polymerase chain reactions
(RT-PCR) in 8–13 overlapping cDNA fragments spanning the DENV ge-
nome. Two-step RT-PCR was generated from a cDNA template using a
speciﬁc antisense primer (10666: 5′-AGAACCTGTTGGATCAACAACACC)
and M-MuLV reverse transcriptase (New England Biolabs, Ipswich) as
per manufacturer's instructions. The PCR reaction was performed
using the high-ﬁdelity Phusion polymerase (Finnzymes, Lafayette, CO)
for 35× ampliﬁcation cycles at an annealing temperature approximately
5 °C below the lowest Tm. Ampliﬁed sequences were puriﬁed (Qiagen,
Valencia, CA) and automated sequencing with speciﬁc sequencing
primers for both strands provided consensus sequences.
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The following DENV-4 genome sequences were determined in this
study: INH6412, JF262781; Haiti73, JF262782; India G11337, JF262783;
and the sylvatic strains P75-514 and P73-1120, accession numbers
JF262779 and JF262780 respectively.
The GenBank accession numbers for the genome sequences of
DENV viruses used in the phylogenetic analyses are summarized in
Supplemental Data 4.
Phylogenetic analyses
Sequences were aligned using the ClustalW multiple sequence
alignment function of MacVector® version 8.0 (Accelrys, Cary, NC)
with default gap penalties. Phylogenetic analyses of the aligned ge-
nomic sequences were estimated with maximum likelihood and dis-
tance/neighbor joining using the PAUP* program version 4.10 (D.L.
Swofford, Illinois Natural History Survey, Champaign) under the
general time-reversible model of nucleotide substitution. The pa-
rameter values used for the substitution type, optimal base composi-
tion, proportion of invariable sites, as well as the shape parameter of
the Γ distribution of rate variation among sites were estimated from
the data and are available upon request. We also utilized Bayesian
analysis (MrBayes v3.1.0) where 4 MCMC tree searches of 4 million
generations each were run simultaneously sampling 1 in 100 trees
and computing a 50% majority-rule consensus tree out of the last
9800 sampled trees, where the initial 10% of trees removed as burn
in. Bootstrapping obtained by the Bayesian analysis was used to
place conﬁdence values on grouping within the consensus tree
(Felsenstein, 1985). Character evolution was traced using Maclade
4.08 (Sinauer Associates, Sunderland, MA).
Viral replication kinetics
Comparative multi-step growth curves of all available sylvatic
(P73-1120, P75-215 and P75-514) and selected human (Haiti73,
IndiaG11337, INH6412 and H241) DENV-4 strains were generated
in triplicate on African green monkey kidney (Vero), human hepato-
ma (Huh-7) and Ae. albopictus (C6/36) cells. Huh-7 cells (clone JTC-
39) were obtained from the Japanese Health Sciences Foundation,
Osaka. All 3 cell lines were plated in 12-well plates at 3.6×105,
3.6×105, and 7.5×105 cells per well respectively, and infected with
a MOI of 0.01 per cell in triplicate. Infected dishes containing Huh-7
and Vero cells were incubated for 1 h with periodic gentle rocking
at 37 °C, whereas dishes containing mosquito C6/36 cells were incu-
bated at 28 °C. Viral inocula were removed and cell monolayers
were washed thrice with PBS to remove unadsorbed virus. Two ml
of complete cell media (MEM supplemented with 5% FBS, 2 mM L-
GLUTAMINE, 1% nonessential amino acids (NEAA), and 50 mg/ml
penicillin/streptomycin) was then added and dishes were incubated
at 28 °C or 37 °C for the mosquito or mammalian cell lines respective-
ly. Virus from individual dishes was harvested daily through day 7 pi,
clariﬁed by low speed centrifugation, and assayed in C6/36 cells to de-
termine virus titer by focus forming immunoassay (FFA). Virus yield
at each timepoint is recorded as FFU/cell, represented as the ratio of
the total amount of virus present in the sample by the number of
cells originally infected.
Focus forming assays and immunostaining
Ten-fold serial dilutions of virus in MEM supplemented with 2%
FBS and antibiotics (Invitrogen, Carlsbad, CA), were added in dupli-
cate to conﬂuent C6/36 cell monolayers attached to 24-well Costar®
(Corning, NY) plates, and incubated for 1 h with periodic gentle
rocking to facilitate virus adsorption at 28 °C. Wells were then over-
laid with 1 ml of 0.8% methylcellulose (Sigma-Aldrich, St. Louis)diluted in warm Optimem (Invitrogen) supplemented with 2% FBS,
antibiotics and 1% (w/v) L-glutamine and incubated undisturbed
for 4 days at 28 °C. Methylcellulose overlay was aspirated and cell
monolayer rinsed once with phosphate buffered saline (PBS), pH
7.4 (Invitrogen) followed by ﬁxation with a mixture of ice-cold ace-
tone andmethanol (1:1) solution and allowed to incubate for 30 min
at room temperature (RT). Fixation solution was aspirated and plates
were allowed to air dry. Plates were washed thrice with PBS supplemen-
tedwith 3% FBS, followed by hour-long incubationwith a dengue-speciﬁc
hyperimmunemouse ascitic ﬂuid. Plates were washed thrice followed by
hour-long incubation with a secondary antibody conjugated to horserad-
ish peroxidase (KPL, Gaithersburg, MD). Detection proceeded with the
addition of aminoethylcarbazole (AEC) substrate (ENZO Life sciences,
Farmingdale, CT) prepared according to vendor instructions.
Statistical analyses
To compare multistep replication dynamics, repeated measures
ANOVA was ﬁrst used to compare the replication of each of the seven
strains tested, with each of the three cell lines analyzed separately.
When a signiﬁcant effect of virus was detected, the differences among
the strains were compared using a Tukey–Kramer post-hoc test. Subse-
quently, the replication of the two ecotypes (sylvatic and human) was
compared in each cell line separately using the mean value for each
virus strain at each time point, resulting inN=3 for the sylvatic ecotype
and N=4 for the human ecotype.
Supplementary materials related to this article can be found online
at doi:10.1016/j.virol.2011.11.018.
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